CN114642241B - Composite plant polyphenol chelate and application method thereof - Google Patents
Composite plant polyphenol chelate and application method thereof Download PDFInfo
- Publication number
- CN114642241B CN114642241B CN202210347360.3A CN202210347360A CN114642241B CN 114642241 B CN114642241 B CN 114642241B CN 202210347360 A CN202210347360 A CN 202210347360A CN 114642241 B CN114642241 B CN 114642241B
- Authority
- CN
- China
- Prior art keywords
- chelate
- baicalin
- plant polyphenol
- intestinal
- puerarin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 66
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 65
- 239000013522 chelant Substances 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title abstract description 8
- 239000002131 composite material Substances 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 57
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims abstract description 23
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims abstract description 23
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims abstract description 22
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960003321 baicalin Drugs 0.000 claims abstract description 22
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229910052802 copper Inorganic materials 0.000 claims abstract description 21
- 239000010949 copper Substances 0.000 claims abstract description 21
- MJIBOYFUEIDNPI-HBNMXAOGSA-L zinc 5-[2,3-dihydroxy-5-[(2R,3R,4S,5R,6S)-4,5,6-tris[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]-2-[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxymethyl]oxan-3-yl]oxycarbonylphenoxy]carbonyl-3-hydroxybenzene-1,2-diolate Chemical compound [Zn++].Oc1cc(cc(O)c1O)C(=O)Oc1cc(cc(O)c1O)C(=O)OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c([O-])c([O-])c2)c1 MJIBOYFUEIDNPI-HBNMXAOGSA-L 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241000196324 Embryophyta Species 0.000 claims description 63
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 14
- 239000001263 FEMA 3042 Substances 0.000 claims description 14
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 14
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 14
- 229940033123 tannic acid Drugs 0.000 claims description 14
- 235000015523 tannic acid Nutrition 0.000 claims description 14
- 229920002258 tannic acid Polymers 0.000 claims description 14
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 13
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 12
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 claims description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- -1 butyric acid acyl chloride Chemical class 0.000 claims description 6
- 239000011592 zinc chloride Substances 0.000 claims description 6
- 235000005074 zinc chloride Nutrition 0.000 claims description 6
- 244000046146 Pueraria lobata Species 0.000 claims description 3
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 241000050051 Chelone glabra Species 0.000 claims 1
- 229960003280 cupric chloride Drugs 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 244000144972 livestock Species 0.000 abstract description 16
- 244000144977 poultry Species 0.000 abstract description 16
- 230000000968 intestinal effect Effects 0.000 abstract description 15
- 241001465754 Metazoa Species 0.000 abstract description 10
- 210000004347 intestinal mucosa Anatomy 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 9
- 230000003647 oxidation Effects 0.000 abstract description 7
- 238000007254 oxidation reaction Methods 0.000 abstract description 7
- 238000011161 development Methods 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 241000282414 Homo sapiens Species 0.000 abstract description 5
- 239000000654 additive Substances 0.000 abstract description 5
- 241000700605 Viruses Species 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 230000000996 additive effect Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 239000003640 drug residue Substances 0.000 abstract description 3
- 208000028774 intestinal disease Diseases 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000000273 veterinary drug Substances 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 30
- 206010012735 Diarrhoea Diseases 0.000 description 16
- 239000003651 drinking water Substances 0.000 description 16
- 235000020188 drinking water Nutrition 0.000 description 16
- 235000013594 poultry meat Nutrition 0.000 description 14
- 239000000243 solution Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 241000287828 Gallus gallus Species 0.000 description 10
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 10
- 210000001630 jejunum Anatomy 0.000 description 10
- 229940118019 malondialdehyde Drugs 0.000 description 10
- 230000002354 daily effect Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 235000021050 feed intake Nutrition 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 102000016938 Catalase Human genes 0.000 description 7
- 108010053835 Catalase Proteins 0.000 description 7
- 210000001198 duodenum Anatomy 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 210000004400 mucous membrane Anatomy 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 210000003405 ileum Anatomy 0.000 description 5
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000003871 intestinal function Effects 0.000 description 4
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 3
- 229940015301 baicalein Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000002175 goblet cell Anatomy 0.000 description 3
- 210000003630 histaminocyte Anatomy 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 230000003405 preventing effect Effects 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 description 2
- 229930195730 Aflatoxin Natural products 0.000 description 2
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000005409 aflatoxin Substances 0.000 description 2
- 229960003022 amoxicillin Drugs 0.000 description 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960003722 doxycycline Drugs 0.000 description 2
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 229960003760 florfenicol Drugs 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ICVKYYINQHWDLM-KBEWXLTPSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;2-[(4r,5s,6s,7r,9r,11e,13e,15r,16r)-6-[(2r,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2r,3r,4r,5r,6r)-5-hydroxy-3,4 Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 ICVKYYINQHWDLM-KBEWXLTPSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010048849 Myocardial haemorrhage Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 241001591005 Siga Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000023011 digestive tract development Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000036750 egg laying performance Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000008944 intestinal immunity Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229960001717 tylosin tartrate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compound plant polyphenol chelate and a use method thereof, which belong to the technical field of animal husbandry, and comprise baicalin copper, 4' -butyryl puerarin and zinc tannate, wherein the mass ratio of the raw materials is 1: 3-5: 4-6. The invention can effectively inhibit intestinal bacteria and viruses, enhance the oxidation resistance and the immunity of the intestinal canal, promote the development of intestinal mucosa, thereby improving the intestinal canal function of livestock and poultry; the compound plant polyphenol chelate can reduce the incidence rate of intestinal diseases, promote the health of livestock and poultry and improve the production performance; compared with veterinary drug additives for feeding, the additive has the advantages of no toxic or side effect, no drug residue, no pollution and being beneficial to animal and human health.
Description
Technical Field
The invention relates to the technical field of animal husbandry, in particular to a compound plant polyphenol chelate and a use method thereof.
Background
Plant polyphenols are a class of secondary metabolites with a polyphenol structure that are widely present in plants, and are bioflavonoids with a specific molecular structure. The plant polyphenol is natural antioxidant, has effects of scavenging free radicals, resisting oxidation, resisting aging, resisting allergy, and inflammation, enhancing immunity, resisting tumor, and preventing cancer, and has protecting effects on heart and cerebral vessels. Such as baicalin has antibacterial, diuretic, antiinflammatory, cholesterol reducing, thrombosis resisting, asthma relieving, pathogenic fire purging, toxic substances removing, hemostatic, miscarriage preventing, antiallergic, and spasmolytic effects; tannic acid has been used in medicine for treating laryngopharyngitis, tonsillitis, hemorrhoid, skin herpes, etc., and can be used for preventing diarrhea and intestinal hemorrhage by internal use; puerarin has antipyretic, sedative and coronary blood flow increasing effects, and can be used for protecting acute myocardial hemorrhage caused by posterior pituitrin. However, most plant polyphenols do not perform well in humans and animals due to their low solubility in esters, water, or low ester/water numbers. In order to better exert the bioactive effect of plant polyphenols in protecting human and animal intestinal health, they are generally derived according to their physicochemical properties, in order that these substances are better soluble in water or esters. The animal intestinal canal is a water-soluble system, so that the baicalin copper, the tannic acid zinc and the 4' -butyric acid puerarin are found to have the characteristic of being easily dissolved in water in the existing baicalin, tannic acid and puerarin derivatives, and have better antioxidation property compared with the original plant polyphenol. The substances with the antioxidant function are added into animal feed or drinking water, so that the intestinal functions of livestock and poultry can be improved, the growth performance and the health level of the livestock and poultry can be promoted, the use of growth promoters and therapeutic drugs can be reduced, and a foundation is laid for the healthy and sustainable development of the breeding industry.
The intestinal tract of livestock and poultry is not only the largest digestive absorption organ in the animal body, but also the largest immune organ in the body. The development status and the functions of the intestinal canal are important to the growth and health of livestock and poultry. The intestinal tracts of young livestock and poultry are in rapid development, have imperfect structure and function, and have great limitations on digestion and absorption of nutrients and immune barrier function. In addition, various stresses, bacteria and viruses can promote the intestinal tracts of livestock and poultry to generate excessive oxygen free radicals, so that intestinal mucosa is atrophic, and intestinal epithelium integrity and mucosa barrier are destroyed, thereby causing intestinal dysfunction. Therefore, effective measures are urgently needed to be taken in livestock and poultry breeding production to improve the intestinal development condition of livestock and poultry, maintain and improve the intestinal function, and therefore, we propose a compound plant polyphenol chelate and a use method thereof.
Disclosure of Invention
The invention aims to provide a compound plant polyphenol chelate. The compound plant polyphenol chelate can effectively inhibit enterobacteria and viruses, enhance the oxidation resistance and the immune function of the intestinal tract, promote the development of intestinal mucosa, and further improve the intestinal function of livestock and poultry. The compound plant polyphenol chelate can reduce the incidence rate of intestinal diseases, promote the health of livestock and poultry and improve the production performance, and has the advantages of no toxic or side effect, no drug residue, no pollution and being beneficial to the health of animals and human beings compared with a veterinary drug additive for feeding.
Another object of the present invention is to provide a method of using the complex plant polyphenol chelate.
In order to solve the problems, the invention adopts the following technical scheme:
a compound plant polyphenol chelate comprises baicalin copper, 4' -butyryl puerarin and zinc tannate, wherein the mass ratio of the raw materials is 1: 3-5: 4-6.
As a preferable scheme of the invention, the baicalin copper is a product prepared from baicalin-7-O-beta-D-glucuronide and copper chloride in methanol medium, and the baicalin content is at least 75% and the copper content is 8.5-9.0%.
As a preferable scheme of the invention, the preparation method of the baicalin copper comprises the following steps: baicalin-7-O-beta-D-glucuronide is obtained from baicalein, baicalin-7-O-beta-D-glucuronide and copper chloride are reacted in methanol solution at 50 ℃ for 3 hours according to the mass ratio of 2:1 to obtain sediment, and the filter residue is dried at low temperature to obtain baicalin copper.
As a preferable scheme of the invention, the 4 '-butyric acid acyl puerarin is a product prepared from 8-beta-D-glucopyranose-4', 7-dihydroxyisoflavone and butyric acid acyl chloride in acetone and sodium hydroxide medium, and the puerarin content is at least 85% and the butyric acid content is 7.8-8.2%.
As a preferable scheme of the invention, the preparation method of the 4' -butyryl puerarin comprises the following steps: 8-beta-D-glucopyranose-4', 7-dihydroxyisoflavone is prepared from wild kudzuvine root according to the mass ratio of 1.5:1 weighing 8-beta-D-glucopyranose-4 ', 7-dihydroxyisoflavone and butyric acid acyl chloride, respectively dissolving in saturated sodium hydroxide solution and acetone solution with equal volume, uniformly mixing the two solutions, reacting at 20 ℃ for 2.5h, separating and filtering to obtain 4' -butyric acid puerarin.
As a preferable scheme of the invention, the product of the zinc tannate prepared from tannic acid and zinc chloride in methanol medium has the tannic acid content of at least 80% and the zinc content of 6.0-7.0%.
As a preferable scheme of the invention, the preparation method of the zinc tannate comprises the following steps: tannic acid is obtained from gallnut, and tannic acid and zinc chloride are mixed according to the mass ratio of 1:1.5 reacting in 45 ℃ ethanol solution for 2 hours, and obtaining zinc tannate through spray drying.
The application method of the compound plant polyphenol chelate comprises the steps of adding the compound plant polyphenol chelate into livestock and poultry feed or drinking water according to the weight of 0.01-0.05%; mixing the compound plant polyphenol chelate with water to directly drink water for use; and mixing the compound plant polyphenol chelate with a carrier to prepare a premix, or mixing the compound plant polyphenol chelate with a feed additive and a feed raw material to prepare a premix and a concentrate for feeding livestock and poultry.
Compared with the prior art, the invention has the advantages that:
the scheme can effectively inhibit intestinal bacteria and viruses, enhance the oxidation resistance and the immunity of the intestinal tracts, promote the development of intestinal mucosa, and further improve the intestinal functions of livestock and poultry; the compound plant polyphenol chelate can reduce the incidence rate of intestinal diseases, promote the health of livestock and poultry and improve the production performance; compared with veterinary drug additives for feeding, the additive has the advantages of no toxic or side effect, no drug residue, no pollution and being beneficial to animal and human health.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below in connection with the embodiments of the present invention. It is apparent that the described embodiments are only some embodiments of the present invention, not all embodiments, and that all other embodiments obtained by persons of ordinary skill in the art without making creative efforts based on the embodiments in the present invention are within the protection scope of the present invention.
A compound plant polyphenol chelate comprises baicalin copper, 4' -butyryl puerarin and zinc tannate, wherein the mass ratio of the raw materials is 1: 3-5: 4-6; wherein, the baicalin copper is a product prepared from baicalein-7-O-beta-D-glucuronide and copper chloride in methanol medium, and the baicalein content is at least 75 percent, and the copper content is 8.5-9.0 percent; the puerarin 4 '-butyrate is a product prepared from 8-beta-D-glucopyranose-4', 7-dihydroxyisoflavone and butyric acid acyl chloride in acetone and sodium hydroxide medium, and the puerarin content is at least 85% and the butyric acid content is 7.8-8.2%; the zinc tannate is a product prepared from tannic acid and zinc chloride in methanol medium, wherein the tannic acid content is at least 80%, and the zinc content is 6.0-7.0%.
The preparation method of the baicalin copper comprises the following steps: baicalin-7-O-beta-D-glucuronide is obtained from baicalein, baicalin-7-O-beta-D-glucuronide and copper chloride are reacted in methanol solution at 50 ℃ for 3 hours according to the mass ratio of 2:1 to obtain sediment, and the filter residue is dried at low temperature to obtain baicalin copper;
the preparation method of the 4' -butyryl puerarin comprises the following steps: 8-beta-D-glucopyranose-4', 7-dihydroxyisoflavone is prepared from wild kudzuvine root according to the mass ratio of 1.5:1, weighing 8-beta-D-glucopyranose-4 ', 7-dihydroxyisoflavone and butyric acid acyl chloride, respectively dissolving in saturated sodium hydroxide solution and acetone solution with equal volume, uniformly mixing the two solutions, reacting for 2.5 hours at 20 ℃, separating and filtering to obtain 4' -butyric acid puerarin;
the preparation method of the zinc tannate comprises the following steps: tannic acid is obtained from gallnut, and tannic acid and zinc chloride are mixed according to the mass ratio of 1:1.5 reacting in 45 ℃ ethanol solution for 2 hours, and obtaining zinc tannate through spray drying.
Example 1:
the mass ratio of the baicalin copper to the 4' -butyryl puerarin to the zinc tannate is 1:4: and 5, combining, and uniformly mixing the compounds to obtain the compound plant polyphenol chelate.
The compound plant polyphenol chelate is suitable for piglets in a drinking water drenching mode, and has obvious application effect.
The compound plant polyphenol chelate of the example is used for feeding piglets in a drinking water way. 24 piglets with age of 2.1+/-0.5 kg of 7 days are selected and divided into 3 groups, no medicine or health care agent is added in drinking water of a blank control group, the doxycycline and amoxicillin mixed agent is infused into the drinking water of a test group I, the doxycycline and amoxicillin mixed agent is 0.5g/L, the compound plant polyphenol chelate is 0.5g/L in the drinking water of a test group II, and the weight, diarrhea incidence and diarrhea index of the piglets are counted after the 21-day-age test of the piglets is finished. The results are shown in Table 1.
TABLE 1 influence of the addition of the complex plant polyphenol chelate to the drinking water on piglets
Project | Blank control group | Test group I | Test group II |
21-day-old body weight (kg/man) | 5.19 b ±0.85 | 5.67 a ±0.64 | 5.75 a ±0.47 |
Incidence of diarrhea (%) | 23.27 a ±9.93 | 1.68 b ±0.52 | 1.72 b ±0.57 |
Diarrhea index | 1.35 a ±1.70 | 0.35 b ±0.22 | 0.32 b ±0.19 |
Note that: the same row of shoulder letters indicates significant differences (p < 0.05). The following is similar.
The results show that compared with a blank control group, the feed additive provided by the invention can obviously improve the weight of piglets by 10.79% at 21 days, and reduce the diarrhea incidence rate by 92.61% and the diarrhea index by 74.07%. Compared with the medicine drinking water group, the difference of various observation indexes is not obvious. The results show that the compound plant polyphenol chelate is used for feeding piglets in a drinking water mode, and the compound plant polyphenol chelate has the advantages of replacing medicine drinking water to ensure the growth performance of the piglets.
Example 2:
the mass ratio of the baicalin copper to the 4' -butyryl puerarin to the zinc tannate is 1:5: and 4, combining, and uniformly mixing the compounds to obtain the compound plant polyphenol chelate.
The compound plant polyphenol chelate is suitable for laying hens in a drinking manner, and has obvious application effect.
The compound plant polyphenol chelate compound of the example is used for feeding the laying hens with enteritis in a drinking manner. 300 sea-blue brown laying hens of the same day age, which are infected with mycoplasma and bacillus to cause diarrhea, are selected to be divided into 3 groups, the control group does not receive any treatment, the test I group receives 0.5g/L of tylosin tartrate through drinking water for 5 days, the test II group receives 0.2g/L of the compound plant polyphenol chelate through drinking water for 5 days, and the production performance, the diarrhea incidence and the intestinal score are counted after the test is finished. The results are shown in Table 2.
TABLE 2 influence of addition of the present complex plant polyphenol chelates to layer eggs in drinking water
Project | Control group | Test group I | Test group II |
Feed intake (g/d/only) | 82.06 a ±2.26 | 112.13 b ±1.72 | 111.16 b ±2.41 |
Laying rate (%) | 37.89 c ±7.08 | 76.3 b ±6.48 | 78.05 a ±5.74 |
Incidence of diarrhea (%) | 91.23 c ±0.39 | 5.68 b ±0.52 | 4.80 a ±0.58 |
Intestinal scoring | 4.53 a ±1.07 | 2.47 b ±1.05 | 2.48 b ±0.98 |
The results show that compared with a control group which is not treated, the feed additive provided by the invention can obviously improve the feed intake of the laying hens by 35.46% and the laying rate by 51.45%, reduce the diarrhea rate by 51.6% and reduce the intestinal score by 45.25%. Compared with the drinking water medicine treatment group, the method has the advantages of remarkably improving the laying rate, reducing the diarrhea incidence rate, and having no remarkable difference in feed intake and intestinal score. The results show that the compound plant polyphenol chelate is used for feeding the laying hen in a drinking water manner, so that the egg laying performance and feed intake of the laying hen are guaranteed to be equivalent to the effect of the medicine, and the effect of relieving diarrhea incidence and intestinal scores of the laying hen suffering from enteritis is better than the effect of the medicine.
Example 3:
the mass ratio of the baicalin copper to the 4' -butyryl puerarin to the zinc tannate is 1:3:6, combining, and uniformly mixing the compounds to obtain the compound plant polyphenol chelate.
The compound plant polyphenol chelate is suitable for the suckling piglets and has obvious application effect.
The compound plant polyphenol chelate of the example is used for feeding weaned pigs. The 72 10 day old piglets were divided into three groups, three replicates (columns) of each group, 8 heads per column. The source, the age of the piglets and the weight of the piglets are close, and the sexes are consistent. The basic ration is fed every day, wherein the blank control group is not added with the compound plant polyphenol chelate and the florfenicol premix, 100mg/kg of florfenicol is added in the test group I, and 0.01% of the compound plant polyphenol chelate is added in the test group II. Raising for 21 days. The results are shown in tables 3, 4, 5 and 6.
TABLE 3 influence of addition of Compound plant polyphenol chelate on growth performance of weaned pigs
Project | Blank control group | Test group I | Test group II |
Average daily gain ADG (g) | 103.33 b ±10.21 | 115.00 ab ±10.00 | 119.67±7.55 a |
Average daily feed intake ADFI (g) | 200.57±7.47 | 210.60±10.77 | 215.60±7.93 |
Ratio of weight to weight F/G | 1.94 a ±0.19 | 1.83 b ±0.42 | 1.80 b ±0.13 |
Incidence of diarrhea (%) | 7.60 a ±0.02 | 3.50 b ±0.04 | 3.15 b ±0.04 |
TABLE 4 influence of addition of Compound plant polyphenol chelate on the number of cells related to jejunal mucosa immunity of weaned pigs
Project | Blank control group | Test group I | Test group II |
Lymphocyte (individual/100 IEL) | 53.5 c ±1.6 | 60.2 b ±0.9 | 65.2 a ±1.2 |
Mast cell (individual/intestinal noodle) | 1625 b ±391 | 1899 b ±331 | 2118 a ±433 |
Goblet cell (personal/100 IEL) | 4.6 c ±0.3 | 5.1 b ±0.4 | 6.1 a ±0.4 |
TABLE 5 influence of addition of complex plant polyphenol chelate on the villus height/crypt depth of small intestine of weaned pigs
Project | Blank control group | Test on testGroup I test | Test group II |
Duodenum | 1.12 c ±0.02 | 1.23 b ±0.08 | 1.36 a ±0.07 |
Jejunum | 1.01 c ± 0.09 | 1.12 b ±0.04 | 1.27 a ±0.12 |
Ileum of the body | 1.38 c ±0.10 | 1.51 b ±0.09 | 1.65 a ±0.06 |
TABLE 6 influence of addition of Compound plant polyphenol chelate on antioxidant capacity of intestinal mucosa of weaned pigs
Project | Blank control group | Test group I | Test group II |
MDA (nmol/mg protein) | 1.07 a ± 0.12 | 0.79 b ± 0.20 | 0.81 b ± 0.11 |
SOD (U/mg protein) | 43.28 c ± 3.18 | 49.27 b ± 1.93 | 53.73 a ± 2.06 |
CAT (U/mg protein) | 23.85 c ± 2.72 | 26.63 b ± 2.19 | 31.16 a ± 1.68 |
GSH (mg/g protein) | 21.76 ± 1.54 | 23.11 ± 1.08 | 22.45 ± 1.89 |
The data in tables 3-6 show that when the composite plant polyphenol chelate disclosed by the invention is applied, compared with a blank control group, the daily gain of piglets is improved by 15.81%, the feed weight ratio is reduced by 7.22%, and the diarrhea rate is reduced by 59.21% by adding the composite plant polyphenol chelate in the feed; the numbers of lymphocytes, mast cells and goblet cells in jejunum cells increased by 21.87%, 30.34% and 32.61%, respectively; the ratio of villus height to crypt depth of duodenum, jejunum and ileum increased by 21.43%, 25.74% and 19.56%, respectively; the content of Malondialdehyde (MDA) in intestinal mucosa is reduced by 24.30%, and the activity of superoxide dismutase (SOD) is improved by 24.15% and the activity of Catalase (CAT) is improved by 30.64%; compared with a drug group, the compound plant polyphenol chelate is added into the feed, so that the daily gain of piglets is increased by 4.06%; the material weight ratio is reduced by 1.64%; the diarrhea rate is reduced by 10%; the numbers of lymphocytes, mast cells and goblet cells in jejunum cells were increased by 8.30%, 11.53% and 19.60%, respectively; the ratio of the villus height to the crypt depth of the duodenum, jejunum and ileum is increased by 10.57%, 13.40% and 9.27%, respectively; the content of Malondialdehyde (MDA) in intestinal mucosa is not different, and the activities of super SOD and CAT are respectively improved by 9.05 percent and 17.01 percent.
In a word, the results show that the compound plant polyphenol chelate has the effects of improving the small intestinal mucosa structure of piglets, improving the oxidation resistance of intestinal tracts, and improving the number of intestinal mucosa immune cells, and is superior to antibiotics, so that the compound plant polyphenol chelate can replace antibiotics to promote the intestinal immunity and oxidation resistance in piglet feeds, thereby improving the productivity of piglets.
Example 4:
the mass ratio of the baicalin copper to the 4' -butyryl puerarin to the zinc tannate is 1:5: and 4, combining, and uniformly mixing the compounds to obtain the compound plant polyphenol chelate.
Meanwhile, firstly, 1 part of 75% baicalin is dissolved in 1 part of copper chloride aqueous solution containing 8.5% of copper, and the mixture is obtained by drying at 65 ℃; secondly, 1 part of 85% puerarin and 1 part of 8% butyric acid aqueous solution are dried at 65 ℃ to obtain a second mixture; then 1 part of 80% tannic acid and 1 part of aqueous solution containing 6% zinc chloride are dried at 65 ℃ to obtain a third mixture; finally, three compounds are mixed according to the mass ratio of 1:5:4 to obtain a mixture (hereinafter referred to as a mixture) with the same composition as the compound plant polyphenol chelate.
The compound plant polyphenol chelate of this example was used for broiler feeding experiments. 817 broilers 360 hatched in the same batch are divided into 3 groups of 8 replicates (columns) each, and 15 chickens each. The nutrition level of three groups of basic diets is consistent, wherein the aflatoxin content in the feed is 500 mug/kg, the blank control group is not added with the compound plant polyphenol chelate and the compound of the invention, the test I group is added with 0.04 percent of the compound plant polyphenol chelate consistent with the compound plant polyphenol chelate composition of the example, and the test II group is added with 0.04 percent of the compound plant polyphenol chelate of the example. Raising for 35 days. The results are shown in tables 7, 8 and 9.
TABLE 7 influence of addition of complex plant polyphenol chelates on broiler growth performance
Project | Blank control group | Test group I | Test group II |
Daily gain ADG (g/d) | 16.7 c ±0.12 | 18.3 b ±0.17 | 20.1 a ±0.09 |
Daily feed intake ADFI (g/d) | 32.6 c ±0.2 | 35.2 b ±0.1 | 37.8 a ±0.1 |
Ratio of weight to weight F/G | 1.95 a ±0.02 | 1.92 a ±0.01 | 1.88 b ±0.02 |
TABLE 8 influence of addition of Compound plant polyphenol chelate on antioxidant capacity and SlgA expression level of intestinal empty field mucosa of broiler chickens
Project | Blank control group | Test group I | Test group II |
MDA (nmol/mg protein) | 3.87 a ±0.66 | 2.82 b ±0.71 | 1.96 c ±0.64 |
CAT (U/g protein) | 2.15 c ±0.13 | 3.03 b ±0.20 a | 4.10 a ±0.26 |
Area of expression of SlgA duodenum μm 2 | 4029.21 c ±335.61 | 4518.12 b ±193.15 | 5372.94 a ±167.45 |
TABLE 9 influence of addition of complex plant polyphenol chelates on the small intestine villus height/crypt depth of broilers
Project | Blank control group | Test group I | Test group II |
Duodenum | 1.09 b ±0.17 | 1.21 b ±0.09 | 1.58 a ±0.14 |
Jejunum | 1.18 b ±0.25 | 1.31 b ±0.25 | 1.63 a ±0.33 |
The result shows that when the ration contains 500 mug/kg aflatoxin, the daily gain and the feed intake of the broiler chickens are respectively improved by 20.35 percent and 15.95 percent and the feed weight ratio is reduced by 3.59 percent by applying the composite plant polyphenol chelate disclosed by the invention compared with a blank control group; the ratio of the villus height to the crypt depth of the duodenum and jejunum ileum is increased by 44.95% and 38.14%, respectively; the content of Malondialdehyde (MDA) in jejunum mucous membrane is reduced by 49.35%, and the super CAT activity 90.07% and the mucous membrane SlgA expression level are improved by 33.35%. Compared with a test II group fed with a mixture with the same composition as the compound plant polyphenol chelate compound of the example, the daily gain and the feed intake of the broiler chickens are respectively improved by 9.52 percent and 7.38 percent, and the feed weight ratio is reduced by 2.08 percent; the ratio of the villus height to the crypt depth of the duodenum and jejunum ileum is respectively improved by 30.57 percent and 24.43 percent; the content of Malondialdehyde (MDA) in jejunum mucous membrane is reduced by 30.49%, and the super CAT activity is improved by 35.31% and the mucous membrane SlgA expression quantity is improved by 18.92%.
In conclusion, the results show that the compound plant polyphenol chelate has the advantages of improving the small intestine mucous membrane structure of the broiler chickens, improving the oxidation resistance of the intestinal tracts and increasing the SIgA expression quantity of the intestinal mucous membranes, so that the production performance of the broiler chickens is improved, and the effect is better than that of a mixture with the same composition as that of the compound plant polyphenol chelate.
The foregoing is only a preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art, who is within the scope of the present invention, should make equivalent substitutions or modifications according to the technical solution and the modified concept thereof, within the scope of the present invention.
Claims (1)
1. The compound plant polyphenol chelate is characterized by comprising baicalin copper, 4' -butyryl puerarin and zinc tannate, wherein the mass ratio of the raw materials is 1:3 to 5: 4-6, wherein the preparation method of the baicalin copper comprises the following steps: baicalin-7-O-beta-D-glucuronide is obtained from baical skullcap root, baicalin-7-O-beta-D-glucuronide and cupric chloride are reacted in methanol solution at 50 ℃ for 3 hours according to the mass ratio of 2:1 to obtain precipitate, filter residues are dried at low temperature to obtain baicalin copper, and the baicalin content is at least 75 percent, and the copper content is 8.5-9.0 percent; the preparation method of the 4' -butyryl puerarin comprises the following steps: 8-beta-D-glucopyranose-4', 7-dihydroxyisoflavone is prepared from wild kudzuvine root according to the mass ratio of 1.5:1, weighing 8-beta-D-glucopyranose-4 ', 7-dihydroxyisoflavone and butyric acid acyl chloride, respectively dissolving in saturated sodium hydroxide solution and acetone solution with equal volume, uniformly mixing the two solutions, reacting for 2.5 hours at 20 ℃, separating and filtering to obtain 4' -butyric acid puerarin, wherein the puerarin content is at least 85% and the butyric acid content is 7.8-8.2%; the preparation method of the zinc tannate comprises the following steps: tannic acid is obtained from gallnut, and tannic acid and zinc chloride are mixed according to the mass ratio of 1:1.5 reacting in 45 ℃ ethanol solution for 2 hours, and obtaining zinc tannate through spray drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210347360.3A CN114642241B (en) | 2022-04-01 | 2022-04-01 | Composite plant polyphenol chelate and application method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210347360.3A CN114642241B (en) | 2022-04-01 | 2022-04-01 | Composite plant polyphenol chelate and application method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114642241A CN114642241A (en) | 2022-06-21 |
CN114642241B true CN114642241B (en) | 2024-01-26 |
Family
ID=81995663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210347360.3A Active CN114642241B (en) | 2022-04-01 | 2022-04-01 | Composite plant polyphenol chelate and application method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114642241B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115813882A (en) * | 2022-12-06 | 2023-03-21 | 成都市丸天科技有限责任公司 | A method for enhancing absorption of vitamins and minerals in intestinal tract |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7455851B1 (en) * | 1999-06-25 | 2008-11-25 | Arch Chemicals, Inc. | Pyrithione biocides enhanced by silver, copper, or zinc ions |
CN101703151A (en) * | 2009-06-18 | 2010-05-12 | 北京华牧伟业科技有限公司 | Application of coordination compound of flavone and trace elements to feedstuff industry |
CN102106481A (en) * | 2011-01-11 | 2011-06-29 | 中国科学院亚热带农业生态研究所 | Method for preparing tannin chelate zinc feed additive |
CN112314780A (en) * | 2020-11-25 | 2021-02-05 | 天津邦元生物科技有限公司 | Reinforcing agent for regulating and controlling intestinal health of livestock and poultry and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3159777A1 (en) * | 2020-05-14 | 2021-11-18 | Probioticsmart, LLC | Tetrahydrocurcuminoid-metal complexes, manufacturing methods thereof, and uses thereof |
-
2022
- 2022-04-01 CN CN202210347360.3A patent/CN114642241B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7455851B1 (en) * | 1999-06-25 | 2008-11-25 | Arch Chemicals, Inc. | Pyrithione biocides enhanced by silver, copper, or zinc ions |
CN101703151A (en) * | 2009-06-18 | 2010-05-12 | 北京华牧伟业科技有限公司 | Application of coordination compound of flavone and trace elements to feedstuff industry |
CN102106481A (en) * | 2011-01-11 | 2011-06-29 | 中国科学院亚热带农业生态研究所 | Method for preparing tannin chelate zinc feed additive |
CN112314780A (en) * | 2020-11-25 | 2021-02-05 | 天津邦元生物科技有限公司 | Reinforcing agent for regulating and controlling intestinal health of livestock and poultry and preparation method thereof |
Non-Patent Citations (4)
Title |
---|
Polyphenol composition and antioxidant and metal chelatingactivities of the solid residues from the essential oil industry;R. Sánchez-Vioquea;《Industrial Crops and Products》;第150-159页 * |
真菌毒素;中国人民共和国国家质量监督检验检疫总局;《GB13078-2017》;第4页 * |
葛根素结构修饰的研究进展;张彬;向纪明;;安康学院学报(05);第99-103页 * |
黄曲霉毒素及其分析方法;宋彬彬;《养殖技术顾问》(7);第80页 * |
Also Published As
Publication number | Publication date |
---|---|
CN114642241A (en) | 2022-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112189763A (en) | Preparation process and application of plant essential oil microcapsule | |
CN109770078A (en) | A kind of feed addictive preventing nursing period calf diarrhea and its application method | |
CN103549222A (en) | Compound feed additive for preventing piglet diarrhea and preparation method thereof | |
CN104304679B (en) | A kind of B B-complex C, E immune polysaccharide microemulsion preparation and its preparation method and application | |
CN101934070A (en) | Veterinary antibacterial drug composition containing lysozyme and oligosaccharide and application thereof | |
CN114642241B (en) | Composite plant polyphenol chelate and application method thereof | |
CN109512998A (en) | The application of synergetic effect additive of the esterification derivative of oxygen-containing hydrocarbon derivative as polymyxins | |
CN105558435A (en) | Feed additive for preventing and treating silver carp hemorrhagic disease | |
WO2022241968A1 (en) | Plant essential oil for prevention and treatment of coccidiosis and use thereof | |
CN110755604A (en) | Pharmaceutical composition for preventing and treating poultry adenofibromyositis and application thereof | |
EP1663225B1 (en) | Compositions for veterinary and medical applications | |
CN113397041A (en) | Application of flood dragon wood in livestock breeding | |
CN107307214B (en) | A kind of feed addictive for treating diarrhea of pigs | |
CN117244037B (en) | Composition for preventing and treating calf transfer transportation stress and preparation method thereof | |
CN116549534B (en) | Pharmaceutical composition for promoting growth of egg chicks and regulating intestinal functions | |
KR20030021298A (en) | The composition of immune enhancer and intestinal regulator for animal | |
CN110179758B (en) | Crystalline valnemulin hydrochloride soluble powder capable of being administered by drinking water and application thereof | |
CN117378706A (en) | Feed additive for improving disease resistance of animals and application thereof | |
CN114053330A (en) | Traditional Chinese medicine preparation for treating chicken salpingitis and enteritis as well as preparation method and application thereof | |
CN114711345A (en) | Chinese herbal medicine additive for preventing and treating bacterial rot disease of alepidote fish and application thereof | |
CN105519815A (en) | Feed additive for improving immunity of chickens | |
WO2013015557A2 (en) | Feed composition including a mugwort extract for promoting animal growth | |
CN105707509B (en) | It is a kind of for preventing and treating the feed addictive of grass carp gill rot | |
CN112972545A (en) | Composition for preventing and treating enterogastritis of livestock and poultry | |
CN117379500A (en) | Traditional Chinese medicine composition for treating chicken eimeria tenella and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |